Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Infectious Diseases and Medical Microbiology
Volume 2016 (2016), Article ID 8594107, 7 pages
http://dx.doi.org/10.1155/2016/8594107
Research Article

High-Throughput Analysis of the T Cell Receptor Beta Chain Repertoire in PBMCs from Chronic Hepatitis B Patients with HBeAg Seroconversion

1Hepatology and Cancer Biotherapy Ward, Beijing You’an Hospital, Capital Medical University, Beijing, China
2State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China
3Network Information Center, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China

Received 27 March 2016; Revised 4 July 2016; Accepted 21 July 2016

Academic Editor: Roshanak Tolouei Semnani

Copyright © 2016 Yachao Qu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization, “Hepatitis B,” Fact Sheet 204, WHO, Geneva‎, Switzerland, 2012. View at Google Scholar
  2. H. J. Yim and A. S.-F. Lok, “Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005,” Hepatology, vol. 43, no. 2, pp. S173–S181, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. D. R. Milich, “Immune response to hepatitis B virus proteins: relevance of the murine model,” Seminars in Liver Disease, vol. 11, no. 2, pp. 93–112, 1991. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Boni, A. Penna, A. Bertoletti et al., “Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B,” Journal of Hepatology, vol. 39, no. 4, pp. 595–605, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. T. P. Arstila, A. Casrouge, V. Baron, J. Even, J. Kanellopoulos, and P. Kourilsky, “A direct estimate of the human αβ T cell receptor diversity,” Science, vol. 286, no. 5441, pp. 958–961, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. K. C. Garcia, L. Teyton, and I. A. Wilson, “Structural basis of T cell recognition,” Annual Review of Immunology, vol. 17, pp. 369–397, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Kronenberg, G. Siu, L. E. Hood, and N. Shastri, “The molecular genetics of the T-cell antigen receptor and T-cell antigen recognition,” Annual Review of Immunology, vol. 4, pp. 529–591, 1986. View at Publisher · View at Google Scholar · View at Scopus
  8. B. L. Brady, N. C. Steinel, and C. H. Bassing, “Antigen receptor allelic exclusion: an update and reappraisal,” The Journal of Immunology, vol. 185, no. 7, pp. 3801–3808, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. M.-P. Lefranc, “IMGT, the international ImMunoGeneTics database®,” Nucleic Acids Research, vol. 31, no. 1, pp. 307–310, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Even, A. Lim, I. Puisieux et al., “T-cell repertoires in healthy and diseased human tissues analysed by T-cell receptor β-chain CDR3 size determination: evidence for oligoclonal expansions in tumours and inflammatory diseases,” Research in Immunology, vol. 146, no. 2, pp. 65–80, 1995. View at Publisher · View at Google Scholar · View at Scopus
  11. J. P. Maciejewski, C. O'Keefe, L. Gondek, and R. Tiu, “Immune-mediated bone marrow failure syndromes of progenitor and stem cells: molecular analysis of cytotoxic T cell clones,” Folia Histochemica et Cytobiologica, vol. 45, no. 1, pp. 5–14, 2007. View at Google Scholar · View at Scopus
  12. J. Yang, J. Chen, J. He et al., “Profiling the repertoire of T-cell receptor beta-chain variable genes in peripheral blood lymphocytes from subjects who have recovered from acute hepatitis B virus infection,” Cellular and Molecular Immunology, vol. 11, no. 4, pp. 332–342, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. R. A. Bull, F. Luciani, K. McElroy et al., “Sequential bottlenecks drive viral evolution in early acute hepatitis C virus infection,” PLoS Pathogens, vol. 7, no. 9, Article ID e1002243, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Di Giallonardo, O. Zagordi, Y. Duport et al., “Next-generation sequencing of HIV-1 RNA genomes: determination of error rates and minimizing artificial recombination,” PLoS ONE, vol. 8, no. 9, Article ID e74249, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Zhou, R. Srivastava, V. Grummel, S. Cepok, H.-P. Hartung, and B. Hemmer, “High throughput analysis of TCR-β rearrangement and gene expression in single T cells,” Laboratory Investigation, vol. 86, no. 3, pp. 314–321, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Pennisi, “Semiconductors inspire new sequencing technologies,” Science, vol. 327, no. 5970, p. 1190, 2010. View at Publisher · View at Google Scholar
  17. C. Camacho, G. Coulouris, V. Avagyan et al., “BLAST+: architecture and applications,” BMC Bioinformatics, vol. 10, article 421, 2009. View at Publisher · View at Google Scholar
  18. E. Sandalova, D. Laccabue, C. Boni et al., “Increased levels of arginase in patients with acute hepatitis B suppress antiviral T cells,” Gastroenterology, vol. 143, no. 1, pp. 78–87.e3, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. H.-Y. Dou, J.-C. Wu, W.-L. Peng et al., “Analysis of T cell receptor V(β) gene usage during the course of disease in patients with chronic hepatitis B,” Journal of Biomedical Science, vol. 5, no. 6, pp. 428–434, 1998. View at Google Scholar · View at Scopus
  20. P. Marrack and J. Kappler, “Positive selection of thymocytes bearing αβ T cell receptors,” Current Opinion in Immunology, vol. 9, no. 2, pp. 250–255, 1997. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Miqueu, M. Guillet, N. Degauque, J.-C. Doré, J.-P. Soulillou, and S. Brouard, “Statistical analysis of CDR3 length distributions for the assessment of T and B cell repertoire biases,” Molecular Immunology, vol. 44, no. 6, pp. 1057–1064, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. J.-W. Du, J.-Y. Gu, J. Liu et al., “TCR spectratyping revealed T lymphocytes associated with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation,” Leukemia and Lymphoma, vol. 48, no. 8, pp. 1618–1627, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Okajima, T. Wada, M. Nishida et al., “Analysis of T cell receptor Vβ diversity in peripheral CD4+ and CD8+ T lymphocytes in patients with autoimmune thyroid diseases,” Clinical and Experimental Immunology, vol. 155, no. 2, pp. 166–172, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Leimgruber, M. Ferber, M. Irving et al., “Tcrep 3D: an automated in silico approach to study the structural properties of tcr repertoires,” PLoS ONE, vol. 6, article e26301, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. D. K. Sethi, D. A. Schubert, A.-K. Anders et al., “A highly tilted binding mode by a self-reactive T cell receptor results in altered engagement of peptide and MHC,” The Journal of Experimental Medicine, vol. 208, no. 1, pp. 91–102, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. K. S. Seo, J. Y. Park, D. S. Terman, and G. A. Bohach, “A quantitative real time PCR method to analyze T cell receptor Vβ subgroup expansion by staphylococcal superantigens,” Journal of Translational Medicine, vol. 8, article 2, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Sugyo, K. Yuh, K. Nakamura et al., “An analysis of T cell antigen receptor variable β genes during the clinical course of patients with chronic hepatitis B,” Journal of Gastroenterology and Hepatology, vol. 14, no. 4, pp. 333–338, 1999. View at Publisher · View at Google Scholar · View at Scopus
  28. J. J. Miles, D. C. Douek, and D. A. Price, “Bias in the αΒ T-cell repertoire: implications for disease pathogenesis and vaccination,” Immunology and Cell Biology, vol. 89, no. 3, pp. 375–387, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. N. J. Singh, J. K. Bando, and R. H. Schwartz, “Subsets of nonclonal neighboring CD4+ T cells specifically regulate the frequency of individual antigen-reactive T cells,” Immunity, vol. 37, no. 4, pp. 735–746, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. C.-F. Huang, S.-S. Lin, Y.-C. Ho, F.-L. Chen, and C.-C. Yang, “The immune response induced by hepatitis B virus principal antigens,” Cellular & Molecular Immunology, vol. 3, no. 2, pp. 97–106, 2006. View at Google Scholar · View at Scopus
  31. X.-S. Yao, G.-W. Zhang, L. Ma et al., “Analysis of the CDR3 length of TCR αβ T cells in the peripheral blood of patients with chronic hepatitis B,” Hepatology Research, vol. 35, no. 1, pp. 10–18, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. C. P. Desmond, A. Bartholomeusz, S. Gaudieri, P. A. Revill, and S. R. Lewin, “A systematic review of T-cell epitopes in hepatitis B virus: identification, genotypic variation and relevance to antiviral therapeutics,” Antiviral Therapy, vol. 13, no. 2, pp. 161–175, 2008. View at Google Scholar · View at Scopus
  33. M. G. Ghany and E. C. Doo, “Management of chronic hepatitis B,” Gastroenterology Clinics of North America, vol. 33, no. 3, pp. 563–579, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. R. A. Morgan, M. E. Dudley, J. R. Wunderlich et al., “Cancer regression in patients after transfer of genetically engineered lymphocytes,” Science, vol. 314, no. 5796, pp. 126–129, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. S.-A. Xue, L. Gao, S. Thomas et al., “Development of a Wilms' tumor antigen-specific T-cell receptor for clinical trials: engineered patient's T cells can eliminate autologous leukemia blasts in NOD/SCID mice,” Haematologica, vol. 95, no. 1, pp. 126–134, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. A. J. Gehring, S.-A. Xue, Z. Z. Ho et al., “Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines,” Journal of Hepatology, vol. 55, no. 1, pp. 103–110, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Koh, N. Shimasaki, R. Suwanarusk et al., “A practical approach to immunotherapy of hepatocellular carcinoma using T cells redirected against hepatitis B virus,” Molecular Therapy—Nucleic Acids, vol. 2, article e114, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. K. Krebs, N. Böttinger, L.-R. Huang et al., “T cells expressing a chimeric antigen receptor that binds hepatitis B virus envelope proteins control virus replication in mice,” Gastroenterology, vol. 145, no. 2, pp. 456–465, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Wu, L. Wang, Y. Liu et al., “Transgenic expression of T cell receptors on HBV-specific cytotoxic T lymphocytes,” Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, vol. 29, no. 5, pp. 453–457, 2013. View at Google Scholar · View at Scopus
  40. J. Yang, J. He, H. Lu et al., “Molecular features of the complementarity determining region 3 motif of the T cell population and subsets in the blood of patients with chronic severe hepatitis B,” Journal of Translational Medicine, vol. 9, no. 1, article 210, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Rybicka, P. Stalke, M. Dreczewski, T. Smiatacz, and K. P. Bielawski, “High-throughput matrix-assisted laser desorption ionization-time of flight mass spectrometry as an alternative approach to monitoring drug resistance of hepatitis B virus,” Journal of Clinical Microbiology, vol. 52, no. 1, pp. 9–14, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. H. S. Robins, P. V. Campregher, S. K. Srivastava et al., “Comprehensive assessment of T-cell receptor β-chain diversity in αβ T cells,” Blood, vol. 114, no. 19, pp. 4099–4107, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. Y. Han, X. Liu, Y. Wang et al., “Identification of characteristic TRB V usage in HBV-associated HCC by using differential expression profiling analysis,” OncoImmunology, vol. 4, no. 8, article e1021537, 2015. View at Publisher · View at Google Scholar · View at Scopus
  44. Y. Huang, H. Ma, S. Wei et al., “nalysis of the complementarity determining regions β-chain genomic rearrangement using high-throughput sequencing in periphery cytotoxic T lymphocytes of patients with chronic hepatitis B,” Molecular Medicine Reports, vol. 14, no. 1, pp. 762–768, 2016. View at Publisher · View at Google Scholar
  45. J. Yang, J. Chen, H. Mao et al., “Skewed T-cell receptor beta chain variable gene (TCRBV) usage among different clinical types of patients with chronic HBV infection,” FEMS Immunology and Medical Microbiology, vol. 65, no. 3, pp. 448–455, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. S.-W. Qiao, A. Christophersen, K. E. A. Lundin, and L. M. Sollid, “Biased usage and preferred pairing of α-and β-chains of TCRs specific for an immunodominant gluten epitope in coeliac disease,” International Immunology, vol. 26, no. 1, pp. 13–19, 2014. View at Publisher · View at Google Scholar · View at Scopus
  47. J. R. Oksenberg, S. Stuart, A. B. Begovich et al., “Limited heterogeneity of rearranged T-cell receptor V alpha transcripts in brains of multiple sclerosis patients,” Nature, vol. 353, no. 6339, article 94, 1991. View at Google Scholar
  48. M. Arenz, K.-H. Meyer Zum Büschenfelde, and H. F. Löhr, “Limited T cell receptor Vβ-chain repertoire of liver-infiltrating T cells in autoimmune hepatitis,” Journal of Hepatology, vol. 28, no. 1, pp. 70–77, 1998. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Arenz, S. Pingel, P. Schirmacher, K.-H. Meyer zum Büschenfelde, and H. F. Löhr, “T cell receptor Vβ chain restriction and preferred CDR3 motifs of liver-kidney microsomal antigen (LKM-1)-reactive T cells from autoimmune hepatitis patients,” Liver, vol. 21, no. 1, pp. 18–25, 2001. View at Publisher · View at Google Scholar · View at Scopus
  50. Y. Hoshino, N. Enomoto, N. Izumi, M. Kurosaki, F. Marumo, and C. Sato, “Limited usage of T-cell receptor β chains and sequences of the complementarity determining region 3 of lymphocytes infiltrating in the liver of autoimmune hepatitis,” Hepatology, vol. 22, no. 1, pp. 142–147, 1995. View at Publisher · View at Google Scholar · View at Scopus
  51. U. Moebius, M. Manns, G. Hess, G. Kober, K.-H. Meyer Zum Büschenfelde, and S. C. Meuer, “T cell receptor gene rearrangements of T lymphocytes infiltrating the liver in chronic active hepatitis B and primary biliary cirrhosis (PBC): oligoclonality of PBC-derived T cell clones,” European Journal of Immunology, vol. 20, no. 4, pp. 889–896, 1990. View at Publisher · View at Google Scholar · View at Scopus